Vai al contenuto principale

Fabio Bioletto

Tesi di dottorato

Research topic: "Assessment of non-invasive indices of skeletal fragility in patients with hydroelectrolyte imbalances and other forms of secondary osteoporosis"

Attività di ricerca

Participation in lessons and seminars (PhD 1st year):

Approaches to scientific reasearch:
20/06/2023 (Prof. Benedetta Bussolati): Scientific presentations.
11/07/2023 (Prof. Riccarda Granata): How to write a scientific paper.
13/07/2023 (Prof. Stefania Bruno): How to set up an in vivo experimental model.
20/07/2023 (Prof. Milena Maule): Regression models: from the linear model to the generalised linear models. Interpretation of interactions between predictors.

Pathophysiological basis of diseases:
27/06/2023 (Prof. Gabriella Gruden): Physiopathology of diabetic nephropathy.
04/07/2023 (Prof. Franco Veglio): Update on physiology of hypertension.

Participation to E-Learning courses (PhD 1st year):
E-Learning course "Fair Data"
E-Learning course "Open Science A to Z"

List of publications (PhD 1st year): 

  1. D’Eusebio C, Merlo FD, Ossola M, Bioletto F, Ippolito M, Locatelli M, Francesco A De, Anrò M, Romagnoli R, Strignano P, Bo S, & Aimasso U. Mortality and parenteral nutrition weaning in patients with chronic intestinal failure on home parenteral nutrition: A 30-year retrospective cohort study. Nutrition 2023 107 111915. (doi:10.1016/j.nut.2022.111915)
  2. Bioletto F, Barale M, Prencipe N, Berton AM, Parasiliti-Caprino M, Gasco V, Ghigo E, Procopio M, & Grottoli S. Trabecular bone score as an index of bone fragility in patients with acromegaly: a systematic review and meta-analysis. Neuroendocrinology 2023 113 395–405. (doi:10.1159/000528199)
  3. Bioletto F, Varaldo E, Prencipe N, Benso A, & Berton AM. Long‑term efficacy of empagliflozin as an add‑on treatment for chronic SIAD: a case report and literature review. Hormones 2023 22 343–347. (doi:10.1007/s42000-023-00430-0)
  4. Prencipe N, Motta G, Crespi CM, Albert U, Berton AM, Bona C, Bioletto F, Varaldo E, Cuboni D, Gasco V, Ghigo E, Maina G, & Grottoli S. Psychiatric disorders and anger in patients with controlled acromegaly. Minerva endocrinology 2023 . (doi:10.23736/S2724-6507.23.03960-X)
  5. Varaldo E, Bioletto F, Cuboni D, Prencipe N, Bona C, Barale M, Ghigo E, Grottoli S, Berton AM, & Gasco V. Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. European journal of endocrinology 2023 188 258–265. (doi:10.1093/ejendo/lvad019)
  6. Prencipe N, Marinelli L, Varaldo E, Cuboni D, Berton AM, Bioletto F, Bona C, Gasco V, & Grottoli S. Isolated anterior pituitary dysfunction in adulthood. Frontiers in Endocrinology 2023 14 1100007. (doi:10.3389/fendo.2023.1100007)
  7. Berton AM, Parasiliti-Caprino M, Prencipe N, Bioletto F, Lopez C, Bona C, Caputo M, Rumbolo F, Ponzetto F, Settanni F, Gasco V, Mengozzi G, Ghigo E, Grottoli S, Maccario M, & Benso AS. Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study. Frontiers in Neuroscience 2023 17 1098404. (doi:10.3389/fnins.2023.1098404)
  8. Lopez C, Bima C, Bollati M, Bioletto F, Procopio M, Arata S, Candela DG, Beccuti G, Ghigo E, Maccario M, & Parasiliti-caprino M. Pathophysiology and Management of Glycemic Alterations before and after Surgery for Pheochromocytoma and Paraganglioma. International Journal of Molecular Sciences 2023 24 5153. (doi:10.3390/ijms24065153)
  9. Bioletto F, Cuboni D, Varaldo E, Bona C, Berton AM, Maccario M, & Prencipe N. Severe hypothyroidism as a trigger for Brugada-type ECG abnormalities: a case report and literature review. Archives of Endocrinology and Metabolism 2023 .
  10. Gasco V, Cuboni D, Varaldo E, Bioletto F, Berton AM, Bona C, Prencipe N, Ghigo E, Maccario M, & Grottoli S. GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency? Journal of Endocrinological Investigation 2023 . (doi:10.1007/s40618-023-02081-9)
  11. Bioletto F, Lopez C, Bollati M, Arata S, Procopio M, Ponzetto F, Beccuti G, Mengozzi G, Ghigo E, Maccario M, & Parasiliti-Caprino M. Predictive performance of aldosterone-to-renin ratio in the diagnosis of primary aldosteronism in patients with resistant hypertension. Frontiers in Endocrinology 2023 14 1145186. (doi:10.3389/fendo.2023.1145186)
  12. Varaldo E, Sibilla M, Bioletto F, Cuboni D, Prencipe N, Bona C, Ferrari M, Viglino F, Aversa LS, Grottoli S, Ghigo E, Gasco V, & Berton AM. Neuroendocrine response to diclofenac in healthy subjects: a pilot study. Journal of Endocrinological Investigation 2023 . (doi:10.1007/s40618-023-02118-z)
  13. Bioletto F, Ghigo E, & Parasiliti-Caprino M. Nonfunctional Adrenal Adenomas and Increased Risk of Mortality. JAMA Internal Medicine 2023 .
  14. Bioletto F, Evangelista A, Ciccone G, Brunani A, Ponzo V, Migliore E, Pagano E, Comazzi I, Merlo FD, Rahimi F, Ghigo E, & Bo S. Prediction of Early and Long-Term Hospital Readmission in Patients with Severe Obesity: A Retrospective Cohort Study. Nutrients 2023 15 3648. (doi:10.3390/nu15163648)
  15. Bioletto F, Barale M, Parasiliti-caprino M, Giannelli J, Campioni L, Cappiello V, Chiara M, Carlo D, Ghigo E, Procopio M, & Giordano R. Bone safety of dual-release hydrocortisone in patients with autoimmune primary adrenal insufficiency. Frontiers in Endocrinology 2023 . (doi:10.3389/fendo.2023.1234237)

 

##################################################

Participation in lessons and seminars (PhD 2nd year):

During the PhD 2nd year, it was not possible for this candidate to participate in lessons and seminars, as he was conducting research activities abroad during this period. These courses will be completed during the PhD 3rd year.

List of publications (PhD 2nd year):

  1. Bioletto F, Barale M, Maiorino F, Pusterla A, Fraire F, Arvat E, Ghigo E, & Procopio M. Trabecular bone score as a marker of skeletal fragility across the spectrum of chronic kidney disease: a systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism 2023 . (doi:10.1210/clinem/dgad724)
  2. Varaldo E, Cuboni D, Aversa LS, Sibilla M, Bioletto F, Berton AM, Gasco V, Ghigo E, Prencipe N, & Grottoli S. Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia? Endocrine 2024 . (doi:10.1007/s12020-023-03678-z)
  3. Bioletto F, Prencipe N, Berton AM, Aversa LS, Cuboni D, Varaldo E, Gasco V, Ghigo E, & Grottoli S. Radiomic analysis in pituitary tumors: current knowledge and future perspectives. Journal of Clinical Medicine 2024 . (doi:10.3390/jcm13020336)
  4. Prencipe N, Bona C, Cuboni D, Berton AM, Bioletto F, Varaldo E, Aversa LS, Sibilla M, Gasco V, Ghigo E, & Grottoli S. Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center. Pituitary 2024 . (doi:10.1007/s11102-024-01384-1)
  5. Bioletto F, Sibilla M, Gasco V, Ghigo E, & Grottoli S. Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis. Journal of Endocrinological Investigation 2024 . (doi:10.1007/s40618-024-02356-9)
  6. Varaldo E, Rumbolo F, Prencipe N, Bioletto F, Settanni F, Mengozzi G, Grottoli S, Ghigo E, Brazzi L, Montrucchio G, & Berton AM. Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission. Journal of Clinical Medicine 2024 13 2019. (doi:10.3390/jcm13072019)
  7. Bioletto F, Sibilla M, Berton AM, Prencipe N, Varaldo E, Maiorino F, Cuboni D, Pusterla A, Gasco V, Grottoli S, Ghigo E, Arvat E, Procopio M, & Barale M. Mild hyponatremia is not associated with degradation of trabecular bone microarchitecture despite bone mass loss. The Journal of Clinical Endocrinology & Metabolism 2024 . (doi:10.1210/clinem/dgae234)
  8. Varaldo E, Prencipe N, Bona C, Cuboni D, Aversa LS, Sibilla M, Bioletto F, Berton AM, Gramaglia C, Gasco V, Ghigo E, & Grottoli S. Effect of cabergoline on weight and glucose metabolism in patients with acromegaly. Journal of Endocrinological Investigation 2024 . (doi:10.1007/s40618-024-02396-1)
  9. Varaldo E, Prencipe N, Berton AM, Aversa LS, Bioletto F, Marco R De, Gasco V, Zenga F, & Grottoli S. Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery. Pituitary 2024 .
  10. Varaldo E, Giannone B, Viglino F, Settanni F, Bioletto F, Barale M, Procopio M, Deaglio S, Ghigo E, & Benso A. Decreased trabecular bone score in patients affected by Fabry disease. Journal of Endocrinological Investigation 2024 .
  11. Parasiliti-Caprino M, Roux A, Campioni L, Procopio M, Arata S, Giannelli J, Bollati M, Bima C, Lopez C, Bioletto F, Ghigo E, Arvat E, Maccario M, & Giordano R. Increased cardiometabolic risk and prevalence of ascending aorta dilation in patients with nonfunctioning adrenal incidentaloma: a retrospective propensity score-matched study. Hypertension Research 2024 .
  12. Xu K, Langenhuijsen JF, Vietor CL, Feelders RA, Ginhoven TM van, Elhassan YS, Bioletto F, Parasiliti-Caprino M, Zandee WT, Kruijff S, Backman S, Akerstrom T, Pamporaki C, Bechmann N, Lussey-Lepoutre C, Canu L, Steenaard R V, Driessens N, Velema M, Dreijerink KM, Engelsman AF, Timmers HJ, & Laat JM de. PRAP study - Partial versus radical adrenalectomy in hereditary pheochromocytomas. European Journal of Endocrinology 2024 .
  13. Bioletto F, Berton AM, Barale M, Aversa LS, Sauro L, Presti M, Mocellini F, Sagone N, Ghigo E, Procopio M, & Grottoli S. Skeletal fragility in pituitary disease: how can we predict fracture risk? Pituitary 2024 .
  14. Varaldo E, Sibilla M, Prencipe N, Berton AM, Cuboni D, Aversa LS, Mocellini F, Bioletto F, Ghigo E, Gasco V, & Grottoli S. Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience. Pituitary 2024 .
  15. Bioletto F, Pusterla A, Fraire F, Sauro L, Presti M, Arvat E, Ghigo E, Procopio M, & Barale M. Sex-specific association of chronic proton pump inhibitor use with reduced bone density and quality. The Journal of Clinical Endocrinology & Metabolism 2024 .
  16. Vékony B, Nyirő G, Herold Z, Fekete J, Ceccato F, Gruber S, Kürzinger L, Parasiliti-Caprino M, Bioletto F, Szücs N, Doros A, Szeredás BK, Nazri SKSM, Fell V, Bassiony M, Dank M, Azizan EA, Bancos I, Beuschlein F, & Igaz P. Circulating miRNAs and machine learning for lateralizing primary aldosteronism. Hypertension 2024 .
  17. Beccuti G, Bioletto F, Parasiliti-Caprino M, Benso A, Ghigo E, Cicolin A, & Broglio F. Estimating cardiovascular benefits of tirzepatide in sleep apnea and obesity: insight from the SURMOUNT-OSA trials. Current Obesity Reports 2024 .
  18. Bioletto F, Ponzo V, Goitre I, Stella B, Rahimi F, Parasiliti-Caprino M, Broglio F, Ghigo E, & Bo S. Complementary role of BMI and EOSS in predicting all-cause and cause-specific mortality in people with overweight and obesity. Nutrients 2024 .
Ultimo aggiornamento: 24/10/2024 14:57
Location: https://dott-fisiopatologia.campusnet.unito.it/robots.html
Non cliccare qui!